Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Olga O. Pozdnyakova, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Olga Pozdnyakova and Waihay Wong.
Connection Strength

2.536
  1. Gene expression profiling distinguishes prefibrotic from overtly fibrotic myeloproliferative neoplasms and identifies disease subsets with distinct inflammatory signatures. PLoS One. 2019; 14(5):e0216810.
    View in: PubMed
    Score: 0.836
  2. Myeloproliferative neoplasms: Diagnostic workup of the cythemic patient. Int J Lab Hematol. 2019 May; 41 Suppl 1:142-150.
    View in: PubMed
    Score: 0.835
  3. JAK2, CALR, MPL and ASXL1 mutational status correlates with distinct histological features in Philadelphia chromosome-negative myeloproliferative neoplasms. Haematologica. 2018 02; 103(2):e63-e68.
    View in: PubMed
    Score: 0.755
  4. A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade. Haematologica. 2021 02 01; 106(2):651-654.
    View in: PubMed
    Score: 0.059
  5. Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms. Hum Pathol. 2019 04; 86:1-11.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.